Home › Funds › SARD WEALTH MANAGEMENT GROUP, LLC › ABBV
SARD WEALTH MANAGEMENT GROUP, LLC position in ABBV
ABBVIE INC COM · Health Care
SARD WEALTH MANAGEMENT GROUP, LLC reported holding 1,231 shares of ABBV (ABBVIE INC COM) in its Q2 2026 13F filing — a position valued at US$310K, representing 0.15% of its reported portfolio and ranking #49 among its reported holdings. SARD WEALTH MANAGEMENT GROUP, LLC first reported this position in Q2 2026.
How SARD WEALTH MANAGEMENT GROUP, LLC's ABBV position evolved
SARD WEALTH MANAGEMENT GROUP, LLC first disclosed a stake in ABBV in Q2 2026 at 1,231 shares (US$310K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.23K | $309.89K | New |
About ABBV and 13F data
ABBV (ABBVIE INC COM) is a Health Care company. 222 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABBV
- Vanguard Group 180.78M sh · $41.31B · Q4 2025
- BlackRock Inc 149.49M sh · $37.62B · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 115.40M sh · $29.04B · Q2 2026
- Banque Cantonale Vaudoise 89.31K sh · $22.47B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 48.48M sh · $12.20B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 47.00M sh · $11.81B · Q2 2026
- Geode Capital Management 47.00M sh · $11.81B · Q2 2026
- Morgan Stanley 38.90M sh · $9.79B · Q2 2026
- Capital Research Global Investors 30.10M sh · $7.57B · Q2 2026
- Capital Research Global Investors 30.10M sh · $7.57B · Q2 2026
- Norges Bank Investment Management 25.55M sh · $6.43B · Q2 2026
- Bank of America Corp 21.24M sh · $5.34B · Q2 2026